Safety and efficacy of purified clinoptilolite-tuff treatment in patients with irritable bowel syndrome with diarrhea: Randomized controlled trial

doi:10.3748/wjg.v28.i46.6573

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 46

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5523)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-3) series.

Item

Count

PDF

262

WORD

HTML

2302

Figures (1-5)

360

Tables (1-3)

278

Sum=3247

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

227

Download

470

Sum=697

Publishing Process of This Article

Item

Count

Browse

358

Download

1221

Sum=1579

Dec 14, 2022 (publication date) through Dec 25, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Randomized Controlled Trial

World J Gastroenterol. Dec 14, 2022; 28(46): 6573-6588
Published online Dec 14, 2022. doi: 10.3748/wjg.v28.i46.6573

Full Size Figure Download Figure

Figure 5 Beta diversity of the gut microbiome by treatment group and visit (longitudinal analysis, statistical methods LefSe and Maaslin).

Citation: Anderle K, Wolzt M, Moser G, Keip B, Peter J, Meisslitzer C, Gouya G, Freissmuth M, Tschegg C. Safety and efficacy of purified clinoptilolite-tuff treatment in patients with irritable bowel syndrome with diarrhea: Randomized controlled trial. World J Gastroenterol 2022; 28(46): 6573-6588
URL: https://www.wjgnet.com/1007-9327/full/v28/i46/6573.htm
DOI: https://dx.doi.org/10.3748/wjg.v28.i46.6573